Zinzino AB (publ) reported preliminary sales results for the month and year to date ended May 2024. The revenue in May for Zinzino's sales markets increased by 23 % and amounted to SEK 172.3 million compared to SEK 139.9 million a year ago period. Faun Pharma's external sales increased by 31% and amounted to SEK 9.2 million compared to SEK 7.0 million a year ago period. Overall, the Group increased revenues by 24 % to SEK 181.5 million from SEK 146.9 million compared with the previous year.

Accumulated revenue for January - May 2024 increased by 21 % to SEK 802.2 million from SEK 661.8 million a year ago period.